Future research that could assess in more detail the impact of GLP-1 RAs should include a greater number of subjects, with or without T2D but with excessive weight, while also including multiple insulin resistance, inflammation, and hepatic biomarkers, with an additional focus on body composition, quality of life, and mental health evaluations. The gene discussed is GLP1R; the disease is Insulin resistance.